ImmunityBio Secures $80M Equity Financing

ImmunityBio has recently secured an $80 million equity financing deal, with Wilson Sonsini serving as their advisor. Marty Waters, a key figure at Wilson Sonsini with over 25 years of corporate and securities law experience, played a crucial role in facilitating the financial transaction. Waters is notable for his deep expertise in guiding high-growth life sciences and technology companies through major financial milestones, such as IPOs and strategic partnerships. His impressive track record as a corporate and securities partner includes counsel in more than 50 offerings, highlighting his profound impact on the industry. Recognized annually since 2011 by Chambers USA for his business acumen, Waters is revered for his ability to manage complex negotiations and provide top-tier corporate counsel. This equity financing agreement further cements his and Wilson Sonsini's influential role in the financial advisory landscape.